These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 32120162)
1. Density functional theory study of gold(III)-dithiocarbamate complexes with characteristic anticancer potentials. Lawal MM; Lawal IA; Klink MJ; Tolufashe GF; Ndagi U; Kumalo HM J Inorg Biochem; 2020 May; 206():111044. PubMed ID: 32120162 [TBL] [Abstract][Full Text] [Related]
2. Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl Truong D; Sullivan MP; Tong KKH; Steel TR; Prause A; Lovett JH; Andersen JW; Jamieson SMF; Harris HH; Ott I; Weekley CM; Hummitzsch K; Söhnel T; Hanif M; Metzler-Nolte N; Goldstone DC; Hartinger CG Inorg Chem; 2020 Mar; 59(5):3281-3289. PubMed ID: 32073260 [TBL] [Abstract][Full Text] [Related]
3. Anticancer profile of a series of gold(III) (2-phenyl)pyridine complexes. Rubbiani R; Zehnder TN; Mari C; Blacque O; Venkatesan K; Gasser G ChemMedChem; 2014 Dec; 9(12):2781-90. PubMed ID: 25377650 [TBL] [Abstract][Full Text] [Related]
4. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties. Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862 [TBL] [Abstract][Full Text] [Related]
5. Cobaltoceniumethynyl gold(I) as an unusual heterodinuclear bioorganometallic fragment to study the biological properties of alkynyl gold complexes. Vanicek S; Kopacka H; Wurst K; Vergeiner S; Kankowski S; Schur J; Bildstein B; Ott I Dalton Trans; 2016 Jan; 45(4):1345-8. PubMed ID: 26732365 [TBL] [Abstract][Full Text] [Related]
6. Metal complexes of 3-(4-bromophenyl)-1-pyridin-2-ylprop-2-en-1-one thiosemicarbazone: cytotoxic activity and investigation on the mode of action of the gold(III) complex. Sâmia LB; Parrilha GL; Da Silva JG; Ramos JP; Souza-Fagundes EM; Castelli S; Vutey V; Desideri A; Beraldo H Biometals; 2016 Jun; 29(3):515-26. PubMed ID: 27091443 [TBL] [Abstract][Full Text] [Related]
7. Gold(I) N-heterocyclic carbene complexes with naphthalimide ligands as combined thioredoxin reductase inhibitors and DNA intercalators. Meyer A; Oehninger L; Geldmacher Y; Alborzinia H; Wölfl S; Sheldrick WS; Ott I ChemMedChem; 2014 Aug; 9(8):1794-800. PubMed ID: 24803348 [TBL] [Abstract][Full Text] [Related]
8. De novo design of thioredoxin reductase-targeted heterometallic titanocene-gold compounds of chlorambucil for mechanistic insights into renal cancer. Tabrizi L; Olasunkanmi LO; Fadare OA Chem Commun (Camb); 2019 Dec; 56(2):297-300. PubMed ID: 31808475 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of DFT methods for predicting geometries and NMR spectra of Bi(III) dithiocarbamate complexes with antitumor properties. de Barros Leite NF; Marques RB; Macedo-Filho A; Rocha GB; Martins EPS J Mol Model; 2024 May; 30(6):177. PubMed ID: 38775913 [TBL] [Abstract][Full Text] [Related]
10. Gold(I) thiotetrazolates as thioredoxin reductase inhibitors and antiproliferative agents. Serebryanskaya TV; Lyakhov AS; Ivashkevich LS; Schur J; Frias C; Prokop A; Ott I Dalton Trans; 2015 Jan; 44(3):1161-9. PubMed ID: 25413270 [TBL] [Abstract][Full Text] [Related]
11. Cationic and Neutral N-Heterocyclic Carbene Gold(I) Complexes: Cytotoxicity, NCI-60 Screening, Cellular Uptake, Inhibition of Mammalian Thioredoxin Reductase, and Reactive Oxygen Species Formation. Zhang C; Hemmert C; Gornitzka H; Cuvillier O; Zhang M; Sun RW ChemMedChem; 2018 Jun; 13(12):1218-1229. PubMed ID: 29603648 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of Action of Antitumor Au(I) N-Heterocyclic Carbene Complexes: A Computational Insight on the Targeting of TrxR Selenocysteine. Tolbatov I; Umari P; Marrone A Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473872 [TBL] [Abstract][Full Text] [Related]
13. Proteasome versus Thioredoxin Reductase Competition as Possible Biological Targets in Antitumor Mixed Thiolate-Dithiocarbamate Gold(III) Complexes. Quero J; Cabello S; Fuertes T; Mármol I; Laplaza R; Polo V; Gimeno MC; Rodriguez-Yoldi MJ; Cerrada E Inorg Chem; 2018 Sep; 57(17):10832-10845. PubMed ID: 30117739 [TBL] [Abstract][Full Text] [Related]
14. Metal complexes with 2-acetylpyridine-N(4)-orthochlorophenylthiosemicarbazone: cytotoxicity and effect on the enzymatic activity of thioredoxin reductase and glutathione reductase. Parrilha GL; Ferraz KS; Lessa JA; de Oliveira KN; Rodrigues BL; Ramos JP; Souza-Fagundes EM; Ott I; Beraldo H Eur J Med Chem; 2014 Sep; 84():537-44. PubMed ID: 25058344 [TBL] [Abstract][Full Text] [Related]
15. Novel antitumor adamantane-azole gold(I) complexes as potential inhibitors of thioredoxin reductase. Garcia A; Machado RC; Grazul RM; Lopes MT; Corrêa CC; Dos Santos HF; de Almeida MV; Silva H J Biol Inorg Chem; 2016 Apr; 21(2):275-92. PubMed ID: 26841791 [TBL] [Abstract][Full Text] [Related]
17. Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches. Karaca Ö; Scalcon V; Meier-Menches SM; Bonsignore R; Brouwer JMJL; Tonolo F; Folda A; Rigobello MP; Kühn FE; Casini A Inorg Chem; 2017 Nov; 56(22):14237-14250. PubMed ID: 29095609 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of Thioredoxin Reductase by Triosmium Carbonyl Clusters. Koh WX; Coppo L; Holmgren A; Kong JW; Leong WK Chem Res Toxicol; 2020 Sep; 33(9):2441-2445. PubMed ID: 32786549 [TBL] [Abstract][Full Text] [Related]
19. Chemistry, structure, and biological roles of Au-NHC complexes as TrxR inhibitors. Karaaslan MG; Aktaş A; Gürses C; Gök Y; Ateş B Bioorg Chem; 2020 Jan; 95():103552. PubMed ID: 31911299 [TBL] [Abstract][Full Text] [Related]
20. Gold(I) complex of N,N'-disubstituted cyclic thiourea with in vitro and in vivo anticancer properties-potent tight-binding inhibition of thioredoxin reductase. Yan K; Lok CN; Bierla K; Che CM Chem Commun (Camb); 2010 Nov; 46(41):7691-3. PubMed ID: 20623063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]